Glenmark Pharmaceuticals (BOM:532296) Construction In Progress : ₹4,193 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Construction In Progress?

Glenmark Pharmaceuticals's quarterly construction in progress declined from Sep. 2023 (₹12,214 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹4,193 Mil).

Glenmark Pharmaceuticals's annual construction in progress increased from Mar. 2022 (₹9,629 Mil) to Mar. 2023 (₹11,428 Mil) but then declined from Mar. 2023 (₹11,428 Mil) to Mar. 2024 (₹4,193 Mil).

Glenmark Pharmaceuticals Construction In Progress Historical Data

The historical data trend for Glenmark Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Construction In Progress Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Construction In Progress

Get a 7-Day Free Trial

11,151.93

12,457.63

9,629.22

11,428.27

4,193.24

Glenmark Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															11,428.27	-	12,214.36	-	4,193.24

Glenmark Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Glenmark Pharmaceuticals (BOM:532296) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Construction In Progress

Traded in Other Exchanges

GLENMARK:India

Address

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (BOM:532296) Headlines

No Headlines